Skip to Content

01. February 2012

Roche in 2011: Strong results and positive outlook

Group sales rise 2% 1 (-10% in Swiss francs; +6% in US dollars), excluding Tamiflu; Significant foreign exchange impact of –12 percentage points due to appreciation of the Swiss franc; overall Group sales at 42.5 billion Swiss francs. more

Media: News and Press Releases

Media Releases

All Media Releases

Roche in the Media

August 31, 2011

Roche to maintain lead in targeted drugs

Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine. (Reuters.com)

August 22, 2011

A healthy forecast for pharma

Dow Jones Interview with Severin Schwan

more articles